1. P383 Real-life experience of the efficacy, safety and pharmacokinetic data of switching from intravenous to subcutaneous infliximab in inactive inflammatory bowel disease patients. Results from the ENEIDA registry. (30th January 2023) Authors: Iborra Colomino, M I; Garrido Marín, A; Caballol Oliva, B; Huguet Malavés, J M; Arias García, L; Mesonero Gismero, F; Fernández Prada, S J; Boscá Watts, M M; Ponferrada Díaz, Á; Calvet Calvo, X; Gutiérrez Casbas, A; Ordás Jiménez, I; Ruiz Sanchez, L; Sicilia Aladren, B; Garcia de la Filia, I; Dom... Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P513 Prospective study on patients' satisfaction and impact on quality of life of corticosteroid therapy in patients with Inflammatory Bowel Disease. (30th January 2023) Authors: Navarro Llavat, M; García-Bosch, O; Castro-Poceiro, J; Bargalló García, A; Ruiz Arroyo, D; Navas Bravo, Y; Erice Muñoz, E; Barquero Declara, D; Mata Bilbao, A; Martín Llahí, M; Ariza Solé, X; Hernández Ballesteros, C; Juan Juan, A; Bustamante Robles, K; Berbel Comas, C; Blasco Pelicano, A; Albare... Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗